Learning Center
Immunoglobulin Infusion Insights: Enhancing Patient Comfort and Tolerability During Ig Treatments
Includes a Live Web Event on 04/27/2025 at 1:30 PM (EDT)
This session will explore best practices for administering immunoglobulin (Ig) replacement therapy, covering various Ig products available, and delineate the differences between subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin (IVIG), and facilitated SCIG. Additionally, approved indications for Ig therapy will be reviewed.
The focus will then shift to nursing considerations and best practices for managing patients receiving Ig therapy. The objective of this session is to educate infusion nurses on the technical aspects of Ig therapy and emphasize the importance of enhancing patient tolerability to foster a positive infusion experience. Fostering a positive infusion experience is essential, as immunoglobulin therapy is a long-term treatment, and adherence to this regimen directly influences the patient’s overall clinical outcomes.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Describe current Ig indications and how Ig can be infused through a highly technical infusion requiring knowledgeable nurses to provide a good infusion experience for the patient
• Discuss black box warnings associated with Ig products, common adverse drug reactions, how to minimize the risk of adverse drug reactions (ADRs) during and after infusions, and how to treat ADRs if they do occur
• Explain the importance of technical aspects of Ig infusion, risks associated with Ig therapy, diligent monitoring of patient tolerability during the infusion (vital signs, physical assessment, questioning the patient), obtaining a full medical and medication history from the patient, the importance of patient education regarding potential serious ADRs and how to respond, as well as their disease state
Contact Hours: 1
CRNI® RUs: 2
Suzanne Strasters, MSN-FNP, IgCN
Suzanne Strasters, MSN-FNP, IgCN, is a Nurse Practitioner with 19 years of experience in clinical nursing. She began specializing in immunoglobulin (Ig) infusion therapies in 2012 and has since become an expert on specialty Ig infusion therapy. Ms Strasters has worked for several leaders in the Ig industry, providing specialized clinical education to nurses, clinical staff, and patients on various Ig therapies and associated disease states. Most recently, she served as a Medical Science Liaison, helping to launch a new specialty infusion device specifically for subcutaneous immunoglobulin (SCIG) therapies. Ms Strasters is passionate about ensuring nurses and other clinical staff are well prepared to administer Ig infusions and are educated on the many unique characteristics of Ig products and how to best administer them to a complex patient population. Currently, she is serving as the Head of Clinical Education for GC Biopharma USA and is looking forward to speaking at this year’s INS Conference.
Key:
Complete
Next
Failed
Available
Locked